Drugs / SE
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03330899 Comparator | Sep 2018 → Jan 2020 | avian influenza | Butantan Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03330899 ↗ |
| Modality | Other / unclassified | “two distinct squalene-based oil-in-water adjuvant emulsion formulations (IB160 and SE)” PMID 36256646 ↗ Oct 2022 |